Search

everythinglearnresearchcommunity

for

Search:↓

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Blocking LFA-1 prevents hair loss in mice.

The combination of Lucilia sericata larva secretions and Achillea sintenisii extract significantly improves wound healing in diabetic rats.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Eclipta alba leaf extract shows strong antibacterial effects against certain bacteria but not tuberculosis.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

A new microneedle patch helps treat hair loss by improving drug delivery to hair follicles.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

The new nitric oxide delivery system may effectively treat hair loss by improving hair follicle health and reducing inflammation.

Blocking a specific receptor slows down hair loss in mice.

Apremilast did not work for treating severe alopecia areata.

A new microneedle treatment could effectively regrow hair in androgenic alopecia.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Higher leptin levels link to hair loss.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Activating Tgr5 may help treat hair loss and bone loss.

PCAT1 and HOTAIR levels are lower in people with androgenic alopecia.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Two lotions used day and night may be a good alternative to minoxidil for hair loss, with better cosmetic effects and tolerance.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.